Q: Can you please compare and contrast these two companies? KTOS has great momentum which makes sense. AVAV had the same until its capital raise a week or so ago. If someone wanted a growth tilted investment in the defence sector with an eye to Trump's bill would you choose one over the other and why? What would your entry point be for both?
According to Barron's : "Shares of Vertiv Holdings, a leader in data-center cooling solutions, were falling Thursday after Amazon.com's Amazon Web Services announced the development of a new cooling system of its own. Analysts, however, think the selloff is "overblown."
Probably a wait and see, I would think but have to check with the guru. Any opinion?
Q: Hi folks...need your opinion on Cellebrite...no CEO in long time, now the CFO has left the company also??....Who is making the decisions on purchases/operations..ie: $200M acquisition...if you have no CEO??...stock is steadily drifting lower...1 of my larger holdings, & don't want to be holding onto a broken stock...similar to Aspen Aerogels....thanks for help...still rate Buy, Hold, or Sell, jb
Q: Every announcement in the past few weeks (acquisition; CFO; partnership with NCMEC) has brought on more selling. Is there something amiss with CLBT? Is this a compelling buy or a falling knife.
Q: Hi I've been screening for Donnville like small cap stocks in the USA. Revenue Growth and ROE above 20% and having good gross margin while being rationally priced. I found CWAN and NATL.
Can you please give an opinion on the potential for these stocks? CWAN recently did an acquisition which will change the numbers.
Q: I would like to start a position in the crypto/blockchain space of approximately 5% in my portfolio. How do you best envision me achieving this goal?
Q: I saw a press release how Amazon is making its own cooling for its large data centres. Can you comment on how this might affect VRT? Percent of current business? Still lots of opportunities? How does VRTs produce line compare? How do you rate VRT as a current Buy?
Q: Hello, I've been holding UHN in my RRSP for a while, but the stock has taken a significant hit with a 33% loss. Given its current stagnation, I'm thinking of selling it and reallocating the funds. I have a few options in mind: I could buy a call option with a strike price of $79 expiring on Dec 27, which might give me a chance to recover some losses if the stock rebounds. Alternatively, I could sell UHN and use the proceeds to increase my stake in other healthcare stocks, such as LLY or ISRG, which I believe have more potential. Or, I could cut my losses entirely and exit the healthcare insurance sector. Which direction makes the most sense? Thanks
Q: Thank you for the upgrades. They are very helpful and user friendly.
Could I have your opinion of Newmarket NEU?
More upside or downside from here?
Any insight that you can provide on its fundamentals please.
Which type of investor would this stock be best suited for?
Q: I am very concerned with the performance of Berkshire Hathaway since the announcement of Buffett's retirement—it is down 11% in the past two months, while the S&P 500 is up 12% during these two months. Thanks to BRK-B’s performance in the past few years, it is the biggest single holding in my taxable portfolio. I am considering biting the bullet, paying capital gains taxes, and replacing it with the FT Vest Laddered Buffer ETF (BUFR). Can you share your thoughts on this?